https://regulatorynews.com/fyb206-keytruda-biosimilar-bla Regulatory News en 2026-10-16T05:57:35-04:00 FDA Accepts First Keytruda Biosimilar for Review https://regulatorynews.com/mhra-strategy-2030 Regulatory News en 2026-10-16T05:57:35-04:00 MHRA Publishes Strategy 2030 for the AI Era https://regulatorynews.com/olympus-fda-warning-letter Regulatory News en 2026-10-16T05:57:35-04:00 Olympus Discloses New FDA Warning Letter Over QMS https://regulatorynews.com/neurora-autism-diagnostic-evidence-gap Regulatory News en 2026-10-14T10:49:28-04:00 FDA Clears Neurora AI Tool for Autism Diagnosis https://regulatorynews.com/leads-biolabs-opamtistomig-fast-track-biliary Regulatory News en 2026-10-14T09:37:45-04:00 Leads Biolabs Wins Second FDA Fast Track for BTC Drug https://regulatorynews.com/rougetx-rtx-001-series-a-financing Regulatory News en 2026-10-14T09:37:45-04:00 RougeTx Raises $58 Million Series A for HHT Drug RTX-001 https://regulatorynews.com/vantis-vascular-crossfast-6f-fda-clearance Regulatory News en 2026-10-14T09:37:45-04:00 Vantis Vascular Wins FDA Clearance for 6F CrossFAST